Menu
Your Cart

GLP-1 ELISA Kit

GLP-1 ELISA Kit
GLP-1 ELISA Kit
  • Stock: In Stock
$780.00

Available Options

Description

GLP-1 ELISA Kit 

Catalog Number: GLP1-01-1047

Size: 1 plate (96 wells)

GLP-1 ELISA Kit is a sandwich enzyme-linked immunoassay for the quantitative determination of GLP-1 with high sensitivity and specificity in serum or plasma.

  

Kit Performance

  • Sensitivity: 1 pg/mL
  • Assay Range: 1 – 100 pg/mL
  • Cross-reactivity: There is no cross reaction with native immunoglobulins
  • Recovery rate: 80 – 120% with normal human serum or plasma samples with known concentrations.
  • Precision

(CV (%) = SD/mean X 100)

  • Intra-Assay: CV < 20%
  • Inter-Assay: CV < 20%

Materials Supplied

List of component

Components

  Quantity

High binding Plate

  1 plate

GLP-1

  1 µg

10x Capture

  700 µL

10x Detection

  700 µL

1x Streptavidin (HRP) (Avoid light)

  12 mL

1x Plate Coating Buffer

  15 mL

1x Blocking Buffer

  15 mL

2x Assay Diluent

  30 mL

1x TMB Substrate (Avoid light)

  12 mL

1x Stop Solution

  12 mL

 

Storage Instruction

The components arrive with ice pack, and must immediately be stored at 2-8°C. The kit components are stable at the date specified in CoA.

 

Supplementary information

GLP-1 (Glucagon-Like Peptide-1) is a hormone that helps control blood sugar and appetite after eating. It is released from intestinal L cells when food enters the digestive system.

After a meal, GLP-1 travels through the blood and acts on the pancreas, where it stimulates insulin release and reduces glucagon secretion. These effects help lower blood glucose levels, especially after eating. GLP-1 also acts on the brain and stomach. In the brain, it reduces hunger and increases the feeling of fullness. In the stomach, it slows down gastric emptying, meaning food leaves the stomach more slowly, which helps control blood sugar and prolong satiety.

GLP-1 normally has a very short half-life because it is quickly broken down by the enzyme DPP-4. Because GLP-1 can improve blood sugar control and reduce appetite, drugs that mimic GLP-1 are widely used to treat type 2 diabetes and obesity.